A systematic review of transgender male rodent model methodology
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.70088 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Kai Robertson und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia. Hauptthemen laut MEDLINE: Testosterone, Gender-Affirming Procedures. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Higher degree research student funds, Griffith University.
Abstract (Originalsprache)
Robust preclinical models of transgender male (TGM) gender‐affirming hormone therapy (GAHT) can inform clinicians of the isolated effects of GAHT; however existing models vary significantly in approach. We aimed to assess existing methodology and how it influences circulating sex‐hormone levels in rodent models of TGM GAHT to provide recommendations of best practise. PubMed, Embase, and Scopus databases were systematically searched for studies that investigated GAHT in rodent models and were published from inception to the 1st of August 2024. Study characteristics and methodology were extracted and compared. Post‐intervention circulating sex hormone concentrations were the primary outcome used to determine whether successful gender affirming hormone therapy had been achieved. Sixteen experimental rodent studies were included. Studies were performed on mice ( n = 11) and rats ( n = 5). Subcutaneous (SC) pellets and SC silastic implants were featured in some studies but weekly SC injections of testosterone enanthate was the preferred method. Sesame oil was the preferred solvent for injected testosterone formulations. Weekly doses of ~450 μg (mice) and ~420–900 μg (rats) consistently induced the testosterone levels of the male counterpart. Similarly, 10 mg of unesterified testosterone in a SC silastic implant in mice or 10 mg/100 g in rats were also successful methods. Most studies administered hormones for 6–8 weeks before performing post‐treatment assessments. This review demonstrates that methods largely varied across studies and successfully identifies the effective methodological approaches that improve the reproducibility and accuracy of preclinical models. Representing an integral step forward to bridging gaps in preclinical transgender healthcare research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.
- Translational Cardiology Centre, Baker Institute for Heart and Diabetes, Melbourne, Victoria, Australia.
ORCID-Profile: Kai Robertson
Förderung
- Higher degree research student funds
- Griffith University
Zitieren
APA
Robertson, K., Lane, D., Donner, D., Peart, J., & du Toit, E. (2025). A systematic review of transgender male rodent model methodology. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70088
Vancouver
Robertson K, Lane D, Donner D, Peart J, du Toit E. A systematic review of transgender male rodent model methodology. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70088
BibTeX
@article{Robertson2025,
author = {Robertson, Kai and Lane, Dylan and Donner, Daniel and Peart, Jason and du Toit, Eugene},
title = {A systematic review of transgender male rodent model methodology},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.70088}
}
EUVIMED